{"title":"2013-2022年土耳其脑血管疾病总死亡率和性别特异性死亡率的十年趋势","authors":"Serdar Aykaç","doi":"10.36472/msd.v10i10.1054","DOIUrl":null,"url":null,"abstract":"Objective: Cerebrovascular diseases (CVD) remain a significant global public health concern and a leading cause of mortality. This study aims to assess the current trends in cerebrovascular disease-related mortality in Turkey, with a particular focus on disparities in age and gender. To achieve this, we will utilize mortality data from the Turkish Statistical Institute (TUIK). Methods: Mortality data for ischemic heart disease from 2013 to 2022 were obtained from the TUIK mortality database. Analytical methods involved the use of Joinpoint analysis to calculate both the annual percentage change (APC) and the average annual percentage change (AAPC). This allowed for the identification of significant alterations in trends over the study period. Additionally, we conducted a detailed examination of sex-specific variations, and age-standardized rates (ASRs) were computed. Results: In 2013, the total CVD death rate was 25.2%, with male and female death rates of 22.9% and 27.5%, respectively. This year marked the highest recorded stroke death rate within the provided timeframe. By 2022, these rates had consistently decreased. The total stroke death rate was 19.2%, with males at 18.7% and females at 19.7%. The analysis indicated a decreasing trend in CVD mortality in Turkey from 2013 to 2022. However, this decrease was not statistically significant (APC=1.9, 95% CI: -0.8; 4.3, p=0.123). The decline was more pronounced in females (APC=2.4, 95% CI: -0.7; 4.9, p=0.121) compared to males (APC=1.2, 95% CI: -1.3; 3.8, p=0.2351). Comparatively, the latest available data underscore significant disparities in cerebrovascular disease mortality across European regions. Western Europe had the lowest percentage of total deaths attributed to stroke, with 5.9% in males and 8.2% in females. In contrast, Eastern Europe recorded the highest percentages, with 11.6% in males and 17.5% in females. These disparities were reflected in Age-Standardized Mortality Rates (ASMRs), with Western Europe having the lowest ASMRs for stroke and Eastern Europe having the highest. Conclusion: While there have been global reductions in CVD mortality, Turkey has mirrored these declining trends, albeit at a lower rate than many European countries. The presented results emphasize the need for continual research and improved interventions targeting the observed inequalities in cerebrovascular disease mortality outcomes in Turkey. The regional and sex disparities highlighted necessitate targeted health policies and resource allocation to effectively mitigate cerebrovascular disease-related mortalities.","PeriodicalId":18486,"journal":{"name":"Medical Science and Discovery","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A Decade Trends in Total and Sex-specific Cerebrovascular Disease Mortality in Turkey: 2013-2022\",\"authors\":\"Serdar Aykaç\",\"doi\":\"10.36472/msd.v10i10.1054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Cerebrovascular diseases (CVD) remain a significant global public health concern and a leading cause of mortality. This study aims to assess the current trends in cerebrovascular disease-related mortality in Turkey, with a particular focus on disparities in age and gender. To achieve this, we will utilize mortality data from the Turkish Statistical Institute (TUIK). Methods: Mortality data for ischemic heart disease from 2013 to 2022 were obtained from the TUIK mortality database. Analytical methods involved the use of Joinpoint analysis to calculate both the annual percentage change (APC) and the average annual percentage change (AAPC). This allowed for the identification of significant alterations in trends over the study period. Additionally, we conducted a detailed examination of sex-specific variations, and age-standardized rates (ASRs) were computed. Results: In 2013, the total CVD death rate was 25.2%, with male and female death rates of 22.9% and 27.5%, respectively. This year marked the highest recorded stroke death rate within the provided timeframe. By 2022, these rates had consistently decreased. The total stroke death rate was 19.2%, with males at 18.7% and females at 19.7%. The analysis indicated a decreasing trend in CVD mortality in Turkey from 2013 to 2022. However, this decrease was not statistically significant (APC=1.9, 95% CI: -0.8; 4.3, p=0.123). The decline was more pronounced in females (APC=2.4, 95% CI: -0.7; 4.9, p=0.121) compared to males (APC=1.2, 95% CI: -1.3; 3.8, p=0.2351). Comparatively, the latest available data underscore significant disparities in cerebrovascular disease mortality across European regions. Western Europe had the lowest percentage of total deaths attributed to stroke, with 5.9% in males and 8.2% in females. In contrast, Eastern Europe recorded the highest percentages, with 11.6% in males and 17.5% in females. These disparities were reflected in Age-Standardized Mortality Rates (ASMRs), with Western Europe having the lowest ASMRs for stroke and Eastern Europe having the highest. Conclusion: While there have been global reductions in CVD mortality, Turkey has mirrored these declining trends, albeit at a lower rate than many European countries. The presented results emphasize the need for continual research and improved interventions targeting the observed inequalities in cerebrovascular disease mortality outcomes in Turkey. The regional and sex disparities highlighted necessitate targeted health policies and resource allocation to effectively mitigate cerebrovascular disease-related mortalities.\",\"PeriodicalId\":18486,\"journal\":{\"name\":\"Medical Science and Discovery\",\"volume\":\"10 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Science and Discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36472/msd.v10i10.1054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science and Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36472/msd.v10i10.1054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
目的:脑血管病(CVD)仍然是一个重要的全球公共卫生问题,也是导致死亡的主要原因。本研究旨在评估土耳其脑血管病相关死亡率的当前趋势,特别关注年龄和性别差异。为此,我们将利用土耳其统计研究所(TUIK)的死亡率数据。方法:从TUIK死亡率数据库获取2013 - 2022年缺血性心脏病死亡率数据。分析方法包括使用连接点分析来计算年变化百分比(APC)和平均年变化百分比(AAPC)。这样就可以确定研究期间趋势的重大变化。此外,我们进行了性别特异性变异的详细检查,并计算了年龄标准化率(ASRs)。结果:2013年心血管疾病总死亡率为25.2%,其中男性死亡率为22.9%,女性死亡率为27.5%。今年是有记录以来中风死亡率最高的一年。到2022年,这些比率持续下降。卒中总死亡率为19.2%,其中男性为18.7%,女性为19.7%。分析表明,从2013年到2022年,土耳其心血管疾病死亡率呈下降趋势。然而,这种下降没有统计学意义(APC=1.9, 95% CI: -0.8;4.3, p = 0.123)。女性的下降更为明显(APC=2.4, 95% CI: -0.7;4.9, p=0.121),与男性相比(APC=1.2, 95% CI: -1.3;3.8, p = 0.2351)。相比之下,最新可用数据强调了欧洲各地区脑血管疾病死亡率的显著差异。西欧中风导致的总死亡率最低,男性为5.9%,女性为8.2%。相比之下,东欧的比例最高,男性为11.6%,女性为17.5%。这些差异反映在年龄标准化死亡率(ASMRs)上,西欧中风的年龄标准化死亡率最低,而东欧最高。结论:虽然全球心血管疾病死亡率有所下降,但土耳其也反映了这些下降趋势,尽管其死亡率低于许多欧洲国家。提出的结果强调需要继续研究和改进针对土耳其观察到的脑血管疾病死亡率结果不平等的干预措施。突出的区域和性别差异需要有针对性的卫生政策和资源分配,以有效减少与脑血管疾病有关的死亡率。
A Decade Trends in Total and Sex-specific Cerebrovascular Disease Mortality in Turkey: 2013-2022
Objective: Cerebrovascular diseases (CVD) remain a significant global public health concern and a leading cause of mortality. This study aims to assess the current trends in cerebrovascular disease-related mortality in Turkey, with a particular focus on disparities in age and gender. To achieve this, we will utilize mortality data from the Turkish Statistical Institute (TUIK). Methods: Mortality data for ischemic heart disease from 2013 to 2022 were obtained from the TUIK mortality database. Analytical methods involved the use of Joinpoint analysis to calculate both the annual percentage change (APC) and the average annual percentage change (AAPC). This allowed for the identification of significant alterations in trends over the study period. Additionally, we conducted a detailed examination of sex-specific variations, and age-standardized rates (ASRs) were computed. Results: In 2013, the total CVD death rate was 25.2%, with male and female death rates of 22.9% and 27.5%, respectively. This year marked the highest recorded stroke death rate within the provided timeframe. By 2022, these rates had consistently decreased. The total stroke death rate was 19.2%, with males at 18.7% and females at 19.7%. The analysis indicated a decreasing trend in CVD mortality in Turkey from 2013 to 2022. However, this decrease was not statistically significant (APC=1.9, 95% CI: -0.8; 4.3, p=0.123). The decline was more pronounced in females (APC=2.4, 95% CI: -0.7; 4.9, p=0.121) compared to males (APC=1.2, 95% CI: -1.3; 3.8, p=0.2351). Comparatively, the latest available data underscore significant disparities in cerebrovascular disease mortality across European regions. Western Europe had the lowest percentage of total deaths attributed to stroke, with 5.9% in males and 8.2% in females. In contrast, Eastern Europe recorded the highest percentages, with 11.6% in males and 17.5% in females. These disparities were reflected in Age-Standardized Mortality Rates (ASMRs), with Western Europe having the lowest ASMRs for stroke and Eastern Europe having the highest. Conclusion: While there have been global reductions in CVD mortality, Turkey has mirrored these declining trends, albeit at a lower rate than many European countries. The presented results emphasize the need for continual research and improved interventions targeting the observed inequalities in cerebrovascular disease mortality outcomes in Turkey. The regional and sex disparities highlighted necessitate targeted health policies and resource allocation to effectively mitigate cerebrovascular disease-related mortalities.